Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission
After a diagnosis of Stimulant dependence including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from stimulants during a period lasting between 1 and 12 months.
Differential diagnosis
When diagnosing Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission, the following ICD-11 disorders should be considered in the differential diagnosis:
- Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0)
- Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1)
Frequently asked questions
What disorders are in the differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission?
The differential diagnosis of Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission (6C46.21) includes: Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0), Szkodliwy wzorzec używania środków pobudzających, w tym amfetamin, metamfetaminy lub metylkatynonu (6C46.1).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C46.21 – WHO ICD-11
Open in interactive browser →